The Histone Demethylase KDM1A Sustains the Oncogenic Potential of MLL-AF9 Leukemia Stem Cells
Top Cited Papers
- 17 April 2012
- journal article
- Published by Elsevier BV in Cancer Cell
- Vol. 21 (4), 473-487
- https://doi.org/10.1016/j.ccr.2012.03.014
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemiaNature, 2011
- Function of leukemogenic mixed lineage leukemia 1 (MLL) fusion proteins through distinct partner protein complexesProceedings of the National Academy of Sciences of the United States of America, 2011
- Mutations in Epigenetic Modifiers in Myeloid Malignancies and the Prospect of Novel Epigenetic-Targeted TherapyAdvances in Hematology, 2011
- MLL-Rearranged Leukemia Is Dependent on Aberrant H3K79 Methylation by DOT1LCancer Cell, 2011
- Mapping and analysis of chromatin state dynamics in nine human cell typesNature, 2011
- Coexistence of LMPP-like and GMP-like Leukemia Stem Cells in Acute Myeloid LeukemiaCancer Cell, 2011
- Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III studyThe Lancet Oncology, 2009
- An embryonic stem cell–like gene expression signature in poorly differentiated aggressive human tumorsNature Genetics, 2008
- Histone Methylation-Dependent Mechanisms Impose Ligand Dependency for Gene Activation by Nuclear ReceptorsCell, 2007
- Polycomb complexes repress developmental regulators in murine embryonic stem cellsNature, 2006